Insider Trading activities of Targacept Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Targacept Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Targacept Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Targacept Inc since 2005. The reporting company's ticker symbol is CBIO. The reporting company's CIK number is 1124105.
The total value of stock buying since 2005 is $37,918,654.
The total value of stock sales since 2005 is $50,723,482.
The total value of stock option exercises since 2005 is $6,485,737.


Go to page:  1   2 

Table 2. Detailed insider stock purchases, sales, and option exercises of Targacept Inc insiders (CBIO) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2010-04-29 Caldwell William S (SVP - Drug Discovery and Dev.) Sale 35,100 24.18 848,753
2010-04-29 Caldwell William S (SVP - Drug Discovery and Dev.) Option Ex 35,100 3.65 128,115
2010-04-28 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Sale 14,700 24.00 352,800
2010-04-28 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Option Ex 14,700 1.75 25,725
2010-04-28 Caldwell William S (SVP - Drug Discovery and Dev.) Sale 16,000 24.00 384,000
2010-04-28 Caldwell William S (SVP - Drug Discovery and Dev.) Option Ex 16,000 1.75 28,000
2010-04-27 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Sale 200 24.00 4,800
2010-04-27 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Option Ex 200 1.75 350
2010-04-27 Caldwell William S (SVP - Drug Discovery and Dev.) Sale 315 24.00 7,560
2010-04-27 Caldwell William S (SVP - Drug Discovery and Dev.) Option Ex 315 1.75 551
2010-04-26 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Sale 257 24.00 6,168
2010-04-26 Dunbar Geoffrey C (SVP, Clin. Dev. & Reg. Affairs) Option Ex 257 1.75 449
2010-04-26 Caldwell William S (SVP - Drug Discovery and Dev.) Sale 600 24.00 14,400
2010-04-26 Caldwell William S (SVP - Drug Discovery and Dev.) Option Ex 600 1.75 1,050
2010-04-20 Caldwell William S (SVP - Drug Discovery and Dev.) Sale 15,900 23.00 365,700
2010-04-20 Caldwell William S (SVP - Drug Discovery and Dev.) Option Ex 15,900 5.32 84,667
2010-04-19 Caldwell William S (SVP - Drug Discovery and Dev.) Sale 100 23.00 2,300
2010-04-19 Caldwell William S (SVP - Drug Discovery and Dev.) Option Ex 100 5.10 509
2010-04-16 Caldwell William S (SVP - Drug Discovery and Dev.) Sale 36,946 23.02 850,386
2010-04-16 Caldwell William S (SVP - Drug Discovery and Dev.) Option Ex 36,946 5.10 188,424
2010-03-31 Zorn Peter A (SVP, Lg Affrs, GC and Secrtary) Sale 313 19.41 6,075
2010-03-31 Zorn Peter A (SVP, Lg Affrs, GC and Secrtary) Option Ex 313 5.10 1,596
2010-02-16 Snyderman Ralph Sale 15,000 19.92 298,815
2010-02-16 Snyderman Ralph Option Ex 15,000 8.18 122,775
2010-01-15 Bencherif Merouane (VP, Preclinical Research) Sale 73,108 20.51 1,499,445
2010-01-15 Bencherif Merouane (VP, Preclinical Research) Option Ex 73,108 4.13 302,155
2010-01-04 Bencherif Merouane (VP, Preclinical Research) Sale 7,735 20.81 160,949
2009-12-31 Zorn Peter A (VP, Lg Affrs, GC and Secrtary) Sale 4,404 21.16 93,197
2009-12-31 Zorn Peter A (VP, Lg Affrs, GC and Secrtary) Option Ex 4,404 5.32 23,451
2009-12-16 Debethizy J Donald (President and CEO) Sale 237,930 22.32 5,311,311
2009-12-16 Debethizy J Donald (President and CEO) Option Ex 209,004 2.64 551,352
2009-12-16 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Sale 22,602 21.86 494,170
2009-12-16 Bencherif Merouane (VP, Preclinical Research) Sale 15,532 21.93 340,663
2009-12-16 Bencherif Merouane (VP, Preclinical Research) Option Ex 15,532 8.51 132,177
2009-12-16 Musso Alan A (VP, CFO & Treasurer) Sale 1,000 22.27 22,269
2009-12-16 Musso Alan A (VP, CFO & Treasurer) Option Ex 1,000 5.10 5,100
2009-12-16 Caldwell William S (VP - Drug Discovery and Dev.) Sale 23,201 21.93 508,867
2009-12-16 Caldwell William S (VP - Drug Discovery and Dev.) Option Ex 23,201 3.52 81,783
2009-12-15 Debethizy J Donald (President and CEO) Sale 15,391 22.28 342,926
2009-12-15 Bencherif Merouane (VP, Preclinical Research) Sale 8,056 22.18 178,722
2009-12-15 Bencherif Merouane (VP, Preclinical Research) Option Ex 8,056 8.51 68,556
2009-12-15 Musso Alan A (VP, CFO & Treasurer) Sale 11,809 22.31 263,423
2009-12-15 Musso Alan A (VP, CFO & Treasurer) Option Ex 11,809 5.10 60,225
2009-12-14 Debethizy J Donald (President and CEO) Sale 2,600 22.44 58,341
2009-12-14 Bencherif Merouane (VP, Preclinical Research) Sale 12,935 22.45 290,351
2009-12-14 Bencherif Merouane (VP, Preclinical Research) Option Ex 12,935 5.72 73,988
2009-12-11 Brennan Jeffrey P (VP - Bus. & Commercial Dev.) Sale 94,759 20.90 1,980,557
2009-12-11 Brennan Jeffrey P (VP - Bus. & Commercial Dev.) Option Ex 94,759 4.34 411,538
2009-12-11 Musso Alan A (VP, CFO & Treasurer) Sale 37,223 21.53 801,262
2009-12-11 Musso Alan A (VP, CFO & Treasurer) Option Ex 37,223 1.75 65,140
2009-10-22 Zorn Peter A (VP, Lg Affrs, GC and Secrtary) Sale 6,035 20.64 124,586
2009-10-22 Zorn Peter A (VP, Lg Affrs, GC and Secrtary) Option Ex 6,035 5.55 33,494
2009-10-21 Zorn Peter A (VP, Lg Affrs, GC and Secrtary) Sale 91,898 21.00 1,930,317
2009-10-21 Zorn Peter A (VP, Lg Affrs, GC and Secrtary) Option Ex 91,898 3.83 352,153
2009-10-20 Zorn Peter A (VP, Lg Affrs, GC and Secrtary) Sale 23,650 21.40 506,157
2009-10-20 Zorn Peter A (VP, Lg Affrs, GC and Secrtary) Option Ex 23,650 4.16 98,336
2009-10-20 Brennan Jeffrey P (VP - Bus. & Commercial Dev.) Sale 13,978 21.95 306,803
2009-10-20 Brennan Jeffrey P (VP - Bus. & Commercial Dev.) Option Ex 13,978 1.75 24,461
2009-10-19 Zorn Peter A (VP, Lg Affrs, GC and Secrtary) Sale 5,800 22.68 131,515
2009-10-19 Zorn Peter A (VP, Lg Affrs, GC and Secrtary) Option Ex 5,800 5.10 29,579
2009-10-19 Brennan Jeffrey P (VP - Bus. & Commercial Dev.) Sale 5,800 22.68 131,515
2009-10-19 Brennan Jeffrey P (VP - Bus. & Commercial Dev.) Option Ex 5,800 1.75 10,150
2009-10-16 Bvf Inc/il (Other) Sale 638,400 23.60 15,063,048
2009-09-18 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Sale 11,000 17.19 189,101
2009-09-18 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Option Ex 11,000 1.75 19,250
2009-09-16 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Sale 9,050 16.27 147,225
2009-09-16 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Option Ex 9,050 1.75 15,837
2009-09-15 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Sale 950 16.02 15,214
2009-09-15 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Option Ex 950 1.75 1,662
2009-09-08 Debethizy J Donald (President and CEO) Sale 851 15.00 12,765
2009-09-08 Debethizy J Donald (President and CEO) Option Ex 851 1.75 1,489
2009-09-04 Debethizy J Donald (President and CEO) Sale 11,149 15.02 167,469
2009-09-04 Debethizy J Donald (President and CEO) Option Ex 11,149 1.75 19,510
2009-09-04 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Sale 10,000 15.02 150,190
2009-09-04 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Option Ex 10,000 1.75 17,500
2009-09-04 Musso Alan A (VP, CFO & Treasurer) Sale 8,000 15.07 120,528
2009-09-04 Musso Alan A (VP, CFO & Treasurer) Option Ex 8,000 1.75 14,000
2009-09-04 Caldwell William S (VP - Drug Discovery and Dev.) Sale 2,100 15.07 31,644
2009-09-04 Caldwell William S (VP - Drug Discovery and Dev.) Option Ex 2,100 1.75 3,675
2009-08-31 Debethizy J Donald (President and CEO) Sale 9,400 14.54 136,647
2009-08-31 Debethizy J Donald (President and CEO) Option Ex 9,400 1.75 16,450
2009-08-31 Musso Alan A (VP, CFO & Treasurer) Sale 5,400 14.50 78,300
2009-08-31 Musso Alan A (VP, CFO & Treasurer) Option Ex 5,400 1.75 9,450
2009-08-31 Caldwell William S (VP - Drug Discovery and Dev.) Sale 13,955 14.54 202,877
2009-08-31 Caldwell William S (VP - Drug Discovery and Dev.) Option Ex 13,955 1.75 24,421
2009-08-28 Debethizy J Donald (President and CEO) Sale 600 14.50 8,700
2009-08-28 Debethizy J Donald (President and CEO) Option Ex 600 1.75 1,050
2009-08-28 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Sale 7,900 14.04 110,900
2009-08-28 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Option Ex 7,900 1.75 13,825
2009-08-28 Musso Alan A (VP, CFO & Treasurer) Sale 600 14.50 8,700
2009-08-28 Musso Alan A (VP, CFO & Treasurer) Option Ex 600 1.75 1,050
2009-08-28 Caldwell William S (VP - Drug Discovery and Dev.) Sale 5,400 14.29 77,176
2009-08-28 Caldwell William S (VP - Drug Discovery and Dev.) Option Ex 5,400 1.75 9,450
2009-08-27 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Option Ex 2,100 1.75 3,675
2009-08-27 Caldwell William S (VP - Drug Discovery and Dev.) Sale 1,600 14.00 22,406
2009-08-27 Caldwell William S (VP - Drug Discovery and Dev.) Option Ex 1,600 1.75 2,800
2009-08-24 Debethizy J Donald (President and CEO) Sale 2,400 13.52 32,440
2009-08-24 Debethizy J Donald (President and CEO) Option Ex 2,400 1.75 4,200
2009-08-24 Musso Alan A (VP, CFO & Treasurer) Sale 2,500 13.54 33,862
2009-08-24 Musso Alan A (VP, CFO & Treasurer) Option Ex 2,500 1.75 4,375
2009-08-14 Debethizy J Donald (President and CEO) Sale 4,600 13.51 62,132
2009-08-14 Debethizy J Donald (President and CEO) Option Ex 4,600 1.75 8,050
2009-08-14 Musso Alan A (VP, CFO & Treasurer) Sale 4,500 13.51 60,781
2009-08-14 Musso Alan A (VP, CFO & Treasurer) Option Ex 4,500 1.75 7,875
2009-08-11 Caldwell William S (VP - Drug Discovery and Dev.) Sale 6,780 12.69 86,024
2009-08-11 Caldwell William S (VP - Drug Discovery and Dev.) Option Ex 6,780 2.34 15,865
2009-08-10 Brennan Jeffrey P (VP - Bus. & Commercial Dev.) Sale 15,000 12.63 189,390
2009-08-10 Brennan Jeffrey P (VP - Bus. & Commercial Dev.) Option Ex 15,000 1.75 26,250
2009-08-07 Debethizy J Donald (President and CEO) Sale 5,700 12.03 68,553
2009-08-07 Debethizy J Donald (President and CEO) Option Ex 5,700 1.75 9,975
2009-08-07 Musso Alan A (VP, CFO & Treasurer) Sale 5,700 12.03 68,553
2009-08-07 Musso Alan A (VP, CFO & Treasurer) Option Ex 5,700 1.75 9,975
2009-08-07 Caldwell William S (VP - Drug Discovery and Dev.) Sale 771 12.02 9,265
2009-08-07 Caldwell William S (VP - Drug Discovery and Dev.) Option Ex 771 1.75 1,349
2009-07-30 Caldwell William S (VP - Drug Discovery and Dev.) Sale 636 12.00 7,632
2009-07-30 Caldwell William S (VP - Drug Discovery and Dev.) Option Ex 636 1.75 1,113
2009-07-29 Debethizy J Donald (President and CEO) Sale 5,700 11.52 65,692
2009-07-29 Debethizy J Donald (President and CEO) Option Ex 5,700 1.75 9,975
2009-07-29 Musso Alan A (VP, CFO & Treasurer) Sale 5,263 11.53 60,666
2009-07-29 Musso Alan A (VP, CFO & Treasurer) Option Ex 5,263 1.75 9,210
2009-07-29 Caldwell William S (VP - Drug Discovery and Dev.) Sale 693 12.00 8,316
2009-07-29 Caldwell William S (VP - Drug Discovery and Dev.) Option Ex 693 1.75 1,212
2009-07-28 Debethizy J Donald (President and CEO) Sale 2,600 11.01 28,615
2009-07-28 Debethizy J Donald (President and CEO) Option Ex 2,600 1.75 4,550
2009-07-28 Bencherif Merouane (VP, Preclinical Research) Sale 41,213 10.39 428,120
2009-07-28 Bencherif Merouane (VP, Preclinical Research) Option Ex 41,213 2.59 106,659
2009-07-28 Musso Alan A (VP, CFO & Treasurer) Sale 3,037 11.02 33,479
2009-07-28 Musso Alan A (VP, CFO & Treasurer) Option Ex 3,037 1.75 5,314
2009-07-27 Bencherif Merouane (VP, Preclinical Research) Sale 42,271 10.14 428,712
2009-07-27 Bencherif Merouane (VP, Preclinical Research) Option Ex 42,271 3.54 149,427
2009-07-14 Bvf Inc/il (10% Owner) Buy 9,516 2.99 28,490
2009-07-13 Bvf Inc/il (10% Owner) Buy 2,200 2.89 6,360
2009-07-10 Bvf Inc/il (10% Owner) Buy 2,000 2.79 5,578
2009-07-09 Bvf Inc/il (10% Owner) Buy 21,500 3.10 66,650
2009-03-17 Brown Julia R Buy 7,500 3.03 22,725
2008-08-27 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Sale 2,100 14.00 29,400
2008-08-19 Debethizy J Donald (President and CEO) Sale 1,700 10.00 17,000
2008-08-19 Debethizy J Donald (President and CEO) Option Ex 1,700 1.75 2,975
2008-08-19 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Sale 1,281 10.00 12,810
2008-08-18 Debethizy J Donald (President and CEO) Sale 900 10.01 9,009
2008-08-18 Debethizy J Donald (President and CEO) Option Ex 900 1.75 1,575
2008-08-18 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Sale 700 10.00 7,000
2008-08-15 Debethizy J Donald (President and CEO) Sale 100 10.00 1,000
2008-08-15 Debethizy J Donald (President and CEO) Option Ex 100 1.75 175
2008-08-15 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Sale 100 10.00 1,000
2008-08-15 Musso Alan A (VP, CFO & Treasurer) Sale 600 10.00 6,000
2008-08-15 Musso Alan A (VP, CFO & Treasurer) Option Ex 600 1.75 1,050
2008-08-14 Debethizy J Donald (President and CEO) Sale 1,473 10.00 14,730
2008-08-14 Debethizy J Donald (President and CEO) Option Ex 1,473 1.75 2,577
2008-08-14 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Sale 1,473 10.00 14,730
2008-08-14 Musso Alan A (VP, CFO & Treasurer) Sale 1,623 10.00 16,230
2008-08-14 Musso Alan A (VP, CFO & Treasurer) Option Ex 1,623 1.75 2,840
2008-08-13 Debethizy J Donald (President and CEO) Sale 2,324 10.00 23,240
2008-08-13 Debethizy J Donald (President and CEO) Option Ex 2,324 1.75 4,067
2008-08-13 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Sale 2,149 10.00 21,490
2008-08-13 Musso Alan A (VP, CFO & Treasurer) Sale 7,777 10.00 77,770
2008-08-13 Musso Alan A (VP, CFO & Treasurer) Option Ex 7,777 1.75 13,609
2008-08-11 Debethizy J Donald (President and CEO) Sale 100 10.00 1,000
2008-08-11 Debethizy J Donald (President and CEO) Option Ex 100 1.75 175
2008-08-08 Brennan Jeffrey P (VP - Bus. & Commercial Dev.) Sale 10,000 9.59 95,900
2008-08-08 Brennan Jeffrey P (VP - Bus. & Commercial Dev.) Option Ex 10,000 1.75 17,500
2008-07-30 Dunbar Geoffrey C (VP, Clin. Dev. & Reg. Affairs) Sale 5,000 9.02 45,105
2007-08-31 Desouza Errol B Option Ex 3,333 .08 249
2007-05-29 Jones Elaine V Option Ex 5,333 .08 399
2007-03-05 Burrill Steven Option Ex 1,000 .08 75
2007-02-23 Jones Elaine V Option Ex 1,000 .08 75
2007-02-06 Sandell Scott D (10% Owner) Option Ex 1,000 .08 75
2007-02-06 Barrett M James (Director) Option Ex 1,000 .08 75
2007-02-06 Morris Peter (10% Owner) Option Ex 1,000 .08 75
2007-02-06 Perry Mark W (10% Owner) Option Ex 1,000 .08 75
2007-02-06 Barris Peter J (10% Owner) Option Ex 1,000 .08 75
2007-02-06 Kramlich C Richard (10% Owner) Option Ex 1,000 .08 75
2007-02-06 Newhall Charles W Iii (10% Owner) Option Ex 1,000 .08 75
2007-02-01 Richard John P Option Ex 1,000 .08 75
2007-02-01 Desouza Errol B Option Ex 1,000 .08 75
2006-11-06 Dunbar Geoffrey C (VP Clin. Dev. & Reg. Affairs) Option Ex 11,856 1.75 20,748
2006-04-12 Sandell Scott D (10% Owner) Buy 350,000 9.00 3,150,000
2006-04-12 Nea Partners 10 L P (10% Owner) Buy 350,000 9.00 3,150,000
2006-04-12 Barrett M James (Director) Buy 350,000 9.00 3,150,000
2006-04-12 Trainor Iii Eugene A (10% Owner) Buy 350,000 9.00 3,150,000
2006-04-12 New Enterprise Associates 10 L P (10% Owner) Buy 350,000 9.00 3,150,000
2006-04-12 Morris Peter (10% Owner) Buy 350,000 9.00 3,150,000
2006-04-12 Perry Mark W (10% Owner) Buy 350,000 9.00 3,150,000
2006-04-12 Barris Peter J (10% Owner) Buy 350,000 9.00 3,150,000
2006-04-12 Kramlich C Richard (10% Owner) Buy 350,000 9.00 3,150,000
2006-04-12 Newhall Charles W Iii (10% Owner) Buy 350,000 9.00 3,150,000
Go to page:  1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of CBIO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Targacept Inc (symbol CBIO, CIK number 1124105) see the Securities and Exchange Commission (SEC) website.